Form 8-K - Current report:
SEC Accession No. 0000950170-23-044135
Filing Date
2023-08-23
Accepted
2023-08-23 16:06:58
Documents
12
Period of Report
2023-08-18
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K grph-20230818.htm   iXBRL 8-K 65916
  Complete submission text file 0000950170-23-044135.txt   190431

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20230818_pre.xml EX-101.PRE 10228
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20230818_lab.xml EX-101.LAB 13904
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20230818.xsd EX-101.SCH 2466
6 EXTRACTED XBRL INSTANCE DOCUMENT grph-20230818_htm.xml XML 4860
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 231197632
SIC: 2836 Biological Products, (No Diagnostic Substances)